X @The Wall Street Journal
The Wall Street Journal·2026-07-24 08:00
The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic dermatitis. https://t.co/f98ip3vobw ...
The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic dermatitis. https://t.co/f98ip3vobw ...